Which Cognitive Domains Predict Progression From MCI to Dementia in Parkinson’s Disease?March 6, 2017Parkinson's DiseaseMovement DisordersAlzheimer's & Cognition
Sublingual Apomorphine Film May Induce On State in Patients With Parkinson’s Disease March 6, 2017Parkinson's DiseaseMovement Disorders
MCI May Predict Dementia in Patients With Parkinson’s DiseaseMarch 3, 2017Parkinson's DiseaseMovement Disorders
What Are the Best Treatments for Nonmotor Symptoms in Parkinson’s Disease?January 31, 2017Parkinson's DiseaseMovement Disorders
Patient Expectations May Be Potent Factor in DBS for Parkinson’s DiseaseJanuary 30, 2017Parkinson's DiseaseMovement Disorders
Gene Mutation Linked to Early Onset of Parkinson’s DiseaseDecember 28, 2016Parkinson's DiseaseMovement Disorders
Treatment Advances in Parkinson’s Disease and Other Movement DisordersDecember 27, 2016Parkinson's DiseaseMovement Disorders
DBS and Optimal Therapy May Have Long-Term Benefit in Early Parkinson’s DiseaseNovember 28, 2016Parkinson's DiseaseMovement Disorders
Safety and Efficacy of Five Years of Levodopa–Carbidopa Intestinal Gel TreatmentNovember 28, 2016Movement DisordersParkinson's Disease
Amantadine Hydrochloride Reduces Levodopa-Induced Dyskinesia in Patients With Parkinson’s DiseaseNovember 2, 2016Parkinson's DiseaseMovement Disorders
Common Genetic Variants Associated With Cognitive Impairment in Parkinson’s DiseaseNovember 2, 2016Parkinson's DiseaseMovement Disorders
How Do Autonomic Symptoms Affect Patients With Early Parkinson’s Disease?November 2, 2016Parkinson's DiseaseMovement Disorders
High-Intensity Exercise May Be Feasible in Patients With Parkinson’s DiseaseNovember 2, 2016Parkinson's DiseaseMovement Disorders
